Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Stereotaxis, Inc. STXS
$1.74
На 18:01, 12 мая 2023
+244.83%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
131722410.00000000
-
week52high
2.75
-
week52low
1.55
-
Revenue
28147000
-
P/E TTM
-8
-
Beta
1.63910000
-
EPS
-0.26000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Aegis Capital | Buy | 12 июл 2022 г. | |
| B. Riley Securities | Buy | 23 июн 2022 г. | |
| Loop Capital | Buy | 05 янв 2022 г. | |
| Craig-Hallum | Buy | 05 янв 2022 г. | |
| Piper Sandler | Overweight | 26 мая 2021 г. | |
| B. Riley Securities | Buy | 02 сент 2022 г. | |
| Cowen & Co. | Outperform | Outperform | 11 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Benfer David | A | 202730 | 54054 | 03 янв 2023 г. |
| Menawat Arun Swarup | A | 679315 | 54054 | 03 янв 2023 г. |
| Fischel Nathan | A | 364530 | 54054 | 03 янв 2023 г. |
| MESSEY ROBERT J | A | 405848 | 54054 | 03 янв 2023 г. |
| Levin Ross B | A | 265003 | 54054 | 03 янв 2023 г. |
| Curet Myriam | A | 78916 | 54054 | 03 янв 2023 г. |
| Levin Ross B | A | 210949 | 15527 | 01 июл 2022 г. |
| Benfer David | A | 148676 | 15527 | 01 июл 2022 г. |
| Menawat Arun Swarup | A | 625261 | 15527 | 01 июл 2022 г. |
| MESSEY ROBERT J | A | 351794 | 15527 | 01 июл 2022 г. |
Новостная лента
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
GlobeNewsWire
18 апр 2023 г. в 09:05
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 first quarter on Tuesday, May 9, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company's results and corporate developments.
Stereotaxis, Inc. (STXS) Q4 2022 Earnings Call Transcript
Seeking Alpha
03 мар 2023 г. в 13:37
Stereotaxis, Inc. (NYSE:STXS ) Q4 2022 Earnings Conference Call March 3, 2023 10:00 AM ET Company Participants David Fischel - CEO & Chairman Kimberly Peery - CFO & Secretary Conference Call Participants Chase Knickerbocker - Craig-Hallum Frank Takkinen - Lake Street Capital Markets Adam Maeder - Piper Sandler Neil Chatterji - B. Riley Securities Operator Good morning.
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
GlobeNewsWire
21 февр 2023 г. в 09:03
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Cowen 43rd Annual Health Care Conference.
Catalysts Are Coming Soon For Stereotaxis
Seeking Alpha
15 февр 2023 г. в 12:11
Stereotaxis, Inc. stock fell in 2022 because of new product delays and weak new orders. These delays and disappointing new orders were caused by macro headwinds that are abating. There are many catalysts in 2023. The Magic catheter getting the CE Mark should turn investor sentiment in favor of Stereotaxis.
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
GlobeNewsWire
02 февр 2023 г. в 09:05
ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2022 fourth quarter and full year ended December 31, 2022 on Friday, March 3, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company's results and corporate developments.